NCI Community Oncology Research Program
Community Oncology and Prevention Trials
University of Rochester NCORP Research Base
For more information, see ClinicalTrials.gov NCT05364086
This study compares treatment outcomes between patients of African American/Black (AA) ancestry and European American/White (EA) ancestry currently receiving immune checkpoint inhibitor treatment. Collecting samples of blood and saliva and health and treatment information from racially diverse patients receiving immune checkpoint inhibitor treatment over time may help doctors better understand health care disparities among all cancer patients.
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Charles S Kamen, PhD, Song Yao, PhD, Jay W. Carlson, Bryan A. Faller, Site Public Contact